- Exchanges
- BSE, NSE
- Industry
- Pharmaceuticals
- Issue
- Book building
Parabolic Drugs IPO
₹64.85
−13.53% on listing
Listing-day close · NSE · 1 Jul 2010 · issue price ₹75
Parabolic Drugs’ ₹200 crore IPO was priced at ₹75 a share. It listed on the NSE on 1 Jul 2010 and closed its first day at ₹64.85, down 13.53% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Listing
Issue details
- Issue size
- ₹200 Cr
- Fresh issue
- ₹185 Cr
- Offer for sale
- ₹15.19 Cr
- Lot size
- 80 shares
- Minimum investment
- ₹6,000
- Face value
- ₹10
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 1.03× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹464 Cr
- ROCE
- 6.21%
- Promoter holding
- 63.21% → 38.04%
From the offer documents.
Listing
- Listing date
- 1 Jul 2010
- Issue price
- ₹75
- Open
- ₹75.00
- High
- ₹75.95
- Low
- ₹63.10
- Close
- ₹64.85
Listing day on the NSE. The close was −13.53% on the issue price.
FAQs
When did the Parabolic Drugs IPO open and close?
It opened on 14 Jun 2010 and closed on 17 Jun 2010.
What was the Parabolic Drugs IPO price?
The price band was ₹75–85 a share. The final issue price was ₹75.
What is the lot size and minimum investment?
One lot is 80 shares, ₹6,000 at ₹75 a share. Retail investors apply in whole lots.
How much did Parabolic Drugs raise?
₹200 crore: ₹185 crore of new shares and ₹15.19 crore offered by existing shareholders.
How many times was the Parabolic Drugs IPO subscribed?
1.03 times overall.
How did Parabolic Drugs list?
It listed on the NSE on 1 Jul 2010 at ₹75.00 and closed the day at ₹64.85, down 13.53% on the ₹75 issue price.
Who is the registrar of the Parabolic Drugs IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app